Tuberculosis

• Understand what tuberculosis is, including its causative pathogen, mode of airborne transmission, and distinction between latent and active disease states
• Identify the role of alveolar macrophages in the initial immune response to *Mycobacterium tuberculosis* and why the bacteria survive despite being engulfed
• Analyze the step-by-step progression from bacterial inhalation to granuloma formation and how this structure contains, but does not eliminate, infection
• Compare latent tuberculosis infection with active symptomatic tuberculosis, recognizing the clinical and immunological differences between the two states
• Evaluate how host factors such as malnutrition, aging, and immunosuppression influence the breakdown of granulomas and reactivation of disease
• Recognize the virulence factors and immune-evasion strategies that make *Mycobacterium tuberculosis* a uniquely dangerous pathogen
• Apply knowledge of tuberculosis pathophysiology to interpret diagnostic scenarios, public health interventions, and treatment strategies used in the US
• Explore how tuberculosis connects to broader topics in microbiology, including modes of transmission, host-pathogen interactions, and antibiotic treatment principles

What Is Tuberculosis? Understanding a Global Pathogen with a Local Impact

Tuberculosis (TB) is a chronic infectious disease caused by *Mycobacterium tuberculosis*, a slow-growing, aerobic bacterium with a uniquely waxy cell wall rich in mycolic acids. Unlike typical Gram-positive or Gram-negative bacteria, *M. tuberculosis* is classified as acid-fast, a property that makes it resistant to standard staining methods and contributes to its remarkable resilience inside the human body. In the US, TB remains a significant public health concern, with the CDC reporting over 8,300 new cases in 2022, particularly in urban centers and among immunocompromised populations.

How Tuberculosis Spreads: Airborne Transmission and Infection

TB spreads through airborne droplet nuclei, microscopic particles expelled when an infected person coughs, speaks, or sneezes. These particles are small enough to remain suspended in the air for hours, making enclosed, poorly ventilated spaces especially high-risk environments. Once inhaled, the bacteria travel deep into the lungs and reach the alveoli, the tiny air sacs responsible for gas exchange. This mode of transmission distinguishes TB from many other common bacterial infections that spread via direct contact or contaminated surfaces, and it explains why infection control in hospitals and correctional facilities across the US is so critical.

The Immune Battle Inside the Lung: Macrophages, Granulomas, and Latency

When *M. tuberculosis* reaches the alveoli, alveolar macrophages, the lung's frontline immune defenders, attempt to engulf and destroy the bacteria through phagocytosis. However, the bacterium's waxy cell wall and virulence factors allow it to survive inside the macrophage by blocking the fusion of the phagosome with lysosomes, effectively disabling the cell's killing machinery. As infected macrophages die and release bacteria into surrounding lung tissue, the immune system mounts an inflammatory response. Other immune cells, including T lymphocytes and additional macrophages, are recruited to the site, eventually forming a tightly organized structure called a granuloma. This walled-off cluster contains the bacteria, preventing widespread infection and pushing the host into a latent TB state, clinically silent and noninfectious, but not cured.

Active Tuberculosis: When the Granuloma Breaks Down

Latency is not permanent. If the host's immune system becomes compromised, through HIV infection, malnutrition, diabetes, aging, or immunosuppressive medications, granulomas can lose structural integrity, releasing viable bacteria back into the lung tissue. The bacteria then replicate rapidly, causing the hallmark symptoms of active tuberculosis: persistent cough, night sweats, unexplained weight loss, fever, and coughing up blood (hemoptysis). At this stage, the person becomes infectious and can transmit TB to others. Treatment involves a multi-drug antibiotic regimen, typically isoniazid, rifampin, pyrazinamide, and ethambutol, administered over six to nine months. Understanding this progression from latency to active disease is essential for AP Biology students, MCAT test-takers, and nursing students preparing for the NCLEX, as TB pathophysiology appears across standardized exam curricula at every level.